PA

Philip Astley-sparke

Executive Chairman at Replimune Group Inc

Boston, Massachusetts

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Biotechnology
Commercialization
Lifesciences
Vaccines
Clinical Trials
Strategy
Life Sciences
Oncology
Pharmaceutical Industry
Mergers & Acquisitions
Biopharmaceuticals
FDA
Start-ups
Clinical Development
Immunology
Mergers

Lists including Philip

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people